PT90760A - Processo para a preparacao de complexos beta-ciclodextrina e de sais de ibuprofen e composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de complexos beta-ciclodextrina e de sais de ibuprofen e composicoes farmaceuticas que os contem

Info

Publication number
PT90760A
PT90760A PT90760A PT9076089A PT90760A PT 90760 A PT90760 A PT 90760A PT 90760 A PT90760 A PT 90760A PT 9076089 A PT9076089 A PT 9076089A PT 90760 A PT90760 A PT 90760A
Authority
PT
Portugal
Prior art keywords
beta
pharmaceutical compositions
contain
preparation
ibuprofen
Prior art date
Application number
PT90760A
Other languages
English (en)
Other versions
PT90760B (pt
Inventor
Christopher Hunter
David Yau
Original Assignee
Reckitt & Colmann Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reckitt & Colmann Prod Ltd filed Critical Reckitt & Colmann Prod Ltd
Publication of PT90760A publication Critical patent/PT90760A/pt
Publication of PT90760B publication Critical patent/PT90760B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT90760A 1988-06-09 1989-06-06 Processo para a preparacao de complexos beta-ciclodextrina e de sais de ibuprofen e composicoes farmaceuticas que os contem PT90760B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888813682A GB8813682D0 (en) 1988-06-09 1988-06-09 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PT90760A true PT90760A (pt) 1989-12-29
PT90760B PT90760B (pt) 1994-10-31

Family

ID=10638367

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90760A PT90760B (pt) 1988-06-09 1989-06-06 Processo para a preparacao de complexos beta-ciclodextrina e de sais de ibuprofen e composicoes farmaceuticas que os contem

Country Status (18)

Country Link
US (1) US5019563A (pt)
EP (1) EP0346006B1 (pt)
JP (1) JPH02243649A (pt)
KR (1) KR910000138A (pt)
AT (1) ATE83924T1 (pt)
AU (1) AU609988B2 (pt)
CA (1) CA1320192C (pt)
DE (1) DE68904121T2 (pt)
DK (1) DK280789A (pt)
ES (1) ES2052914T3 (pt)
FI (1) FI93692C (pt)
GB (2) GB8813682D0 (pt)
GR (1) GR3006729T3 (pt)
IE (1) IE61616B1 (pt)
NO (1) NO175039B (pt)
NZ (1) NZ229204A (pt)
PT (1) PT90760B (pt)
ZA (1) ZA893913B (pt)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3827974A1 (de) * 1988-08-18 1990-02-22 Boehringer Mannheim Gmbh Kombinationspraeparate von proteinkinase-c-inhibitoren mit lipiden, lipid-analoga, cytostatica oder inhibitoren von phospholipasen
MY106598A (en) * 1988-08-31 1995-06-30 Australian Commercial Res & Development Ltd Compositions and methods for drug delivery and chromatography.
DE3922441A1 (de) * 1989-07-07 1991-01-17 Pharmatrans Sanaq Ag Ibuprofen- und s-(+)-ibuprofen-zubereitungen und verfahren zu ihrer herstellung
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
FR2660195B1 (fr) * 1990-03-28 1994-10-07 Crinex Sa Laboratoires Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique.
ES2093192T3 (es) * 1991-03-22 1996-12-16 Merck & Co Inc Formulacion farmaceutica con elevado contenido de lisinato de ibuprofeno.
EP1004318A3 (en) * 1991-06-21 2002-08-07 Takeda Chemical Industries, Ltd. Cyclodextrin composition
US5321014A (en) * 1991-06-28 1994-06-14 The United States Of America As Represented By The Department Of Health And Human Services Molecular encapsulation and delivery of alkenes alkynes and long chain alkanes, to living mammalian cells
IT1255007B (it) * 1991-07-01 1995-10-11 Altergon Sa Sale solubile dell'ibuprofen c0n n-(2-idrossietil) pirrolidina e composizioni farmaceutiche che li contengono.
GB9207990D0 (en) * 1992-04-10 1992-05-27 Smithkline Beecham Plc Pharmaceutical composition
IT1272149B (it) * 1993-03-26 1997-06-11 Zambon Spa Composizione farmeceutiche ad attivita' analgesica
HU210922B (en) * 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
CN1088600C (zh) * 1993-07-31 2002-08-07 史密丝克莱恩比彻姆有限公司 布洛芬-β-环糊精配合物的用途
US5582351A (en) * 1993-08-09 1996-12-10 Tsau; Josef Convenient to use aspartame and method of making
US5866162A (en) * 1993-08-10 1999-02-02 Smithkline Beecham P.L.C. Pharmaceutical composition containing a drug/β-cyclodextrin complex in combination with an acid-base couple
GB9316580D0 (en) * 1993-08-10 1993-09-29 Smithkline Beecham Plc Pharmaceutical composition
ZA949715B (en) * 1993-12-14 1996-06-06 Lilly Co Eli Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins and pharmaceutical formulations and methods thereof
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
JPH10500982A (ja) * 1994-05-27 1998-01-27 ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ 医薬組成物
BE1008307A3 (fr) * 1994-06-16 1996-04-02 Europharmaceuticals Sa Sel de nimesulide hydrosoluble, solution aqueuse le contenant, sa preparation et son utilisation.
ZA959469B (en) * 1994-11-15 1996-05-15 South African Druggists Ltd Pharmaceutical composition
US5942501A (en) * 1996-08-16 1999-08-24 Collaborative Laboratories, Inc. Cyclodextrin derivative complex
IT1301966B1 (it) 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica
US6287603B1 (en) * 1999-09-16 2001-09-11 Nestec S.A. Cyclodextrin flavor delivery systems
ES2171110B1 (es) * 2000-03-03 2003-06-16 Aplicaciones Farmacodinamicas Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
US7141555B2 (en) * 2000-12-19 2006-11-28 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US7704975B2 (en) * 2000-12-19 2010-04-27 Cephalon, Inc. Modafinil compound and cyclodextrin mixtures
US6727286B2 (en) 2001-11-02 2004-04-27 Cumberland Pharmaceuticals Inc. Pharmaceutical composition of 2-(4-isobutylphenyl) propionic acid
KR100451485B1 (ko) * 2002-03-28 2004-10-06 주식회사종근당 푸마질롤 유도체 또는 그 염의 포접 화합물, 및 이를포함하는 약제학적 조성물
US20060233873A1 (en) * 2003-01-24 2006-10-19 Julien Meissonnier Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same
FR2850275B1 (fr) * 2003-01-24 2005-04-08 Scherer Technologies Inc R P Capsules molles a macher contenant une substance active a gout masque
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
CA2570649A1 (en) * 2004-06-07 2005-12-22 Strides Arcolab Limited Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
KR100730393B1 (ko) * 2005-06-10 2007-06-20 한국콜마 주식회사 이부프로펜 및 아르기닌을 함유하는 약학 조성물의제조방법
CA2620219A1 (en) * 2005-11-02 2007-05-18 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
BRPI0709382A2 (pt) * 2006-03-16 2011-07-12 Novartis Ag forma de dosagem sólida contendo um agente ativo de sabor mascarado
FR2914187B1 (fr) * 2007-03-28 2011-01-21 Pf Medicament Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique.
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
EP2238973A1 (en) 2009-04-07 2010-10-13 Cephalon France Lyophilized preparations of proteasome inhibitors
ES2347754B8 (es) * 2009-04-27 2012-06-04 Laboratorio De Aplicaciones Farmacodinamicas, S.A Suspension oral de lisinato de ibuprofeno
CN102448499A (zh) * 2009-04-27 2012-05-09 药效学应用实验室股份有限公司 赖氨酸布洛芬口服混悬剂
HUE029953T2 (en) * 2009-04-27 2017-04-28 Laboratorio De Aplicaciones Farm S A Ibuprofen lysinate oral suspension
ES2654331T3 (es) * 2009-06-22 2018-02-13 Wyeth Llc Comprimidos de ibuprofeno de sodio y procedimientos de fabricación de composiciones farmacéuticas que incluyen ibuprofeno de sodio
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法
US10098964B2 (en) 2015-03-12 2018-10-16 The Board Of Trustees Of The University Of Illinois Inclusion complexes and methods for making the same
CN114588107B (zh) * 2022-04-06 2023-04-18 河北一品生物医药有限公司 一种布洛芬赖氨酸盐注射液及其制备方法
GR1010732B (el) * 2023-06-02 2024-07-25 Ιουλια Κλεωνος Τσετη Φαρμακευτικη συνθεση ιβουπροφαινης και παρακεταμολης για απο του στοματος χορηγηση
CN116688154B (zh) * 2023-07-10 2026-04-17 山东新华制药股份有限公司 一种包合物药品的生产方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646837A (en) * 1979-09-27 1981-04-28 Kowa Yakuhin Kogyo Kk Preparation of ibuprofen clathrate compound
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
CA1298290C (en) * 1987-01-09 1992-03-31 Herand M. Markarian Solution ibuprofen complexes, compositions and processes for preparing the same

Also Published As

Publication number Publication date
NO892340L (no) 1989-12-11
GB8813682D0 (en) 1988-07-13
DE68904121D1 (de) 1993-02-11
DE68904121T2 (de) 1993-05-06
KR910000138A (ko) 1991-01-29
DK280789A (da) 1989-12-12
ES2052914T3 (es) 1994-07-16
JPH02243649A (ja) 1990-09-27
NO175039C (pt) 1994-08-24
NO175039B (no) 1994-05-16
NO892340D0 (no) 1989-06-07
ATE83924T1 (de) 1993-01-15
NZ229204A (en) 1992-03-26
IE891757L (en) 1989-12-09
EP0346006B1 (en) 1992-12-30
IE61616B1 (en) 1994-11-16
FI892780L (fi) 1989-12-10
AU609988B2 (en) 1991-05-09
EP0346006A1 (en) 1989-12-13
CA1320192C (en) 1993-07-13
FI892780A0 (fi) 1989-06-07
GB2219585B (en) 1991-11-06
GB8911938D0 (en) 1989-07-12
FI93692B (fi) 1995-02-15
ZA893913B (en) 1990-02-28
GB2219585A (en) 1989-12-13
PT90760B (pt) 1994-10-31
GR3006729T3 (pt) 1993-06-30
AU3492789A (en) 1989-12-14
US5019563A (en) 1991-05-28
FI93692C (fi) 1995-05-26
DK280789D0 (da) 1989-06-08

Similar Documents

Publication Publication Date Title
PT90760A (pt) Processo para a preparacao de complexos beta-ciclodextrina e de sais de ibuprofen e composicoes farmaceuticas que os contem
IT8822399A0 (it) Derivati di monofosforil lipide a e procedimento per la loro preparazione.
MX173630B (es) Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene
PT90962A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ranitidina ou um seu sal
FI873492A7 (fi) Dipyridamolia tai mopidamolia ja O-asetyylisalisyylihappoa tai niiden fysiologisesti siedettäviä suoloja sisältävien lääkevalmisteiden valmistusmenetelmä sekä niiden käyttö tromboosimuodostuksen estämiseksi.
BG92179A (bg) Метод за получаване на 7-заместена-хепт-6-еноена и -хептаноена киселина и техни производни и междинни съединения
PT98297A (pt) Processo para a preparacao de cristais cationicos da hormona de crescimento
PT82307B (pt) Processo para a preparacao de derivados da 4'-demetil-4-epipodofilotoxina e de composicoes farmaceuticas que os contem
PT93067A (pt) Processo para a preparacao de derivados de 2-hidroxiacidos alifaticos e de eteres de 1-benzil-3-hidroximetilindazol, e de composicoes farmaceuticas que os contem
FI892052A7 (fi) Happoadditiosuoloja ja menetelmä niiden valmistamiseksi
ES2060012T5 (es) Polidextrosa modificada y procedimiento para su preparacion.
PT90362A (pt) Metodo para o tratamento de doencas muco-epiteliais e da pele em mamiferos que utiliza acidos 4-quinolinocarboxilicos e seus derivados e processo para a preparacao de composicoes farmaceuticas que contem os mesmos compostos
MX10537A (es) Procedimiento para la preparacion de sales de adicion de acidos cefem cristalizadas y producto resultante
FI890477A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 2,5-diamino-6-fluoriheksaanihapon ja sen suolojen valmistamiseksi
PT92345A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados diterpenoides de labdano e derivados de pirimido(6,1-a)isoquinolina-4-ona
PT90273A (pt) Processo para a preparacao de derivados de aminoacidos
PT89253A (pt) Processo para a preparacao de derivados de 4' e de composicoes farmaceuticas que os contem
DK0478838T3 (da) Ibuprofen- og S-(+)-ibuprofenpræparater og fremgangsmåder til fremstilling heraf
PT97052A (pt) Processo para a preparacao de composicoes farmaceuticas contendo bambuterol, apropriadas para diminuir o teor de lipidos no sangue
PT99146A (pt) Processo para a preparacao de complexos de inclusao com silibinina e de composicoes farmaceuticas que os contem
IT8621934A0 (it) Procedimento per la preparazione di derivati salini dell'acido mercaptoetansolfonico.
IT8822047A0 (it) Acido 8 amino 1 idrossiottan 1,1difosfonico, suoi sali o derivati e relative composizioni farmaceutiche
PT87272A (pt) Processo para a preparacao de derivados da di-hidropiridina
ITMI922157A1 (it) Processo per la preparazione di derivati dell'acido pirrolidin- carbossilico
FI881154A7 (fi) Menetelmä 5-hydroksidiprafenonin ja sen happoadditiosuolojen valmistamiseksi.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940419

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19961031